Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AXSM · against 1,216 other Healthcare companies
Ranked #93 of 1,217 · scores higher than 92% of peers
Bars: peers in each 10-point band of the growth score128 peers with a growth score of 90–100, including AXSM · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | AXSM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 56.9% | 6.1% | 91% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 62.0% | 5.8% | 94% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 81 | 871M USD | 93 | 53 | |
| 93 | 287.6B KRW (≈$207M) | 92 | ||
| 93 | 4.6B CNY (≈$639M) | 92 | 68 | |
| 93 | 2.2B USD | 92 | 82 | |
| 93 | 7.3B USD | 92 | 32 | |
| 93 | 2.7B USD | 92 | 50 | |
| 93 | 250M SEK (≈$25M) | 92 | 44 | |
| 93 | 655M AUD (≈$432M) | 92 | 62 | |
| 93 | 40.2B USD | 92 | 73 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score